Condition: Primary IgA-nephropathy · High-risk · Caucasians · Sponsor: St. Petersburg State Pavlov Medical University
The open-label prospective non-randomised controlled aims to assess the efficacy of the combination of immunosupression (IST) and tonsillectomy (TE) in Caucasian patients at high risk of the IgA-nephropathy.
This description comes directly from the study's public registry record.
Vladimir Dobronravov, Professor, MD, PhD, DMedSci · (812)338-69-01 · dobronravov@nephrolog.ru
Zinaida Kochoyan, Nephrologist · (812)338-69-21 · zinshak@gmail.com
Always discuss trial participation with your own doctor first.
| Research Institute of Nephrology (Pavlov Medical University) | Saint Petersburg, Russia | Recruiting |
| St. Petersburg State Pavlov Medical University | Saint Petersburg, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07074951